IL-6 Receptor α, Human, ELISA Kit, Quantikine (96well)

データシート※最新のデータシートでない場合があります

• 商品コード：DR600
• メーカー：RSD
• 包装：1kit
• 価格： ¥116,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  St端bner S et al. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neurosci. Lett. 1999 Jan;259(3):145-8
  St端bner S et al
  1999/01/01
  
• 備考：
  Species: Human, Application: CSF
• 参照：
  

• No.： 2
• 文献情報：
  Hampel H et al. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Res. 1999 Mar;823(1-2):104-12
  Hampel H et al
  1999/01/01
  
• 備考：
  human cerebrospinal fluid
• 参照：
  

• No.： 3
• 文献情報：
  Gullestad L et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J. Am. Coll. Cardiol. 1999 Dec;34(7):2061-7
  Gullestad L et al
  1999/01/01
  
• 備考：
  Species: Human, Application: Plasma (EDTA)
• 参照：
  

• No.： 4
• 文献情報：
  Keller ET et al. Ovariectomy does not induce osteopenia through interleukin-6 in rhesus monkeys (Macaca mulatta). Bone 2000 Jan;26(1):55-62
  Keller ET et al
  2000/01/01
  
• 備考：
  Species: Primate - Macaca mulatta (Rhesus monkey), Sample type: Bone Marrow Fluid, Serum
• 参照：
  

• No.： 5
• 文献情報：
  Nishimoto N et al. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int. Immunol. 2000 Feb;12(2):187-93
  Nishimoto N et al
  2000/01/01
  
• 備考：
  human fibroblastic synovial cell culture supernate
• 参照：
  

• No.： 6
• 文献情報：
  Giuliani N et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp. Gerontol. 2001 Mar;36(3):547-57
  Giuliani N et al
  2001/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 7
• 文献情報：
  Carstanjen D et al. Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp. Hematol. 2001 Jul;29(7):812-21
  Carstanjen D et al
  2001/01/01
  
• 備考：
  human serum and urine
• 参照：
  

• No.： 8
• 文献情報：
  Khosla S et al. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J. Clin. Endocrinol. Metab. 2002 Apr;87(4):1550-4
  Khosla S et al
  2002/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 9
• 文献情報：
  Holub MC et al. Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells. Immunol. Lett. 2002 Jun;82(1-2):79-84
  Holub MC et al
  2002/01/01
  
• 備考：
  Sample Type: Cell Supernates
• 参照：
  

• No.： 10
• 文献情報：
  Alexandrakis MG et al. Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma. Clin Lab Haematol 2002 Jun;24(3):155-9
  Alexandrakis MG et al
  2002/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 11
• 文献情報：
  Rendina D et al. Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone. Clin. Exp. Rheumatol. ;20(3):359-64
  Rendina D et al
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 12
• 文献情報：
  Rutkowski P et al. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int. J. Cancer 2002 Aug;100(4):463-71
  Rutkowski P et al
  2002/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 13
• 文献情報：
  Sherwin JR et al. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J. Clin. Endocrinol. Metab. 2002 Aug;87(8):3953-60
  Sherwin JR et al
  2002/01/01
  
• 備考：
  Sample Type: Cell Supernates
• 参照：
  

• No.： 14
• 文献情報：
  Porreca E et al. Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. Atherosclerosis 2002 Nov;165(1):159-66
  Porreca E et al
  2002/01/01
  
• 備考：
  Sample Type: Plasma (Citrate)
• 参照：
  

• No.： 15
• 文献情報：
  Chaidos AI et al. Incidence of apoptosis and cell proliferation in multiple myeloma: correlation with bcl-2 protein expression and serum levels of interleukin-6 (IL-6) and soluble IL-6 receptor. Eur. J. Haematol. 2002 Aug;69(2):90-4
  Chaidos AI et al
  2002/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 16
• 文献情報：
  Petrucci MT et al. Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells. Leuk. Lymphoma 2002 Dec;43(12):2369-75
  Petrucci MT et al
  2002/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 17
• 文献情報：
  Sutherland AG et al. Disturbance of pro-inflammatory cytokines in post-traumatic psychopathology. Cytokine 2003 Dec;24(5):219-25
  Sutherland AG et al
  2003/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 18
• 文献情報：
  Rousselot P et al. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice. Eur. J. Haematol. 2004 Mar;72(3):166-71
  Rousselot P et al
  2004/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 19
• 文献情報：
  Marta R et al. Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia. Haematologica 2004 Jun;89(6):657-63
  Marta R et al
  2004/01/01
  
• 備考：
  Sample Type: Cell Lysates,Plasma (Citrate)
• 参照：
  

• No.： 20
• 文献情報：
  Lehtim辰ki KA et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol. 2004 Jul;152(1-2):121-5
  Lehtim辰ki KA et al
  2004/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 21
• 文献情報：
  Beeton CA et al. Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br 2004 Aug;86(6):912-7
  Beeton CA et al
  2004/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 22
• 文献情報：
  Hirota H et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels 2004 Sep;19(5):237-41
  Hirota H et al
  2004/01/01
  
• 備考：
  Sample Type: Plasma (EDTA)
• 参照：
  

• No.： 23
• 文献情報：
  Azar RR et al. Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease. Am. J. Cardiol. 2005 Jan;95(2):23
  Azar RR et al
  2005/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 24
• 文献情報：
  Aronica E et al. Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes. Neuroscience 2005;130(4):927-33
  Aronica E et al
  2005/01/01
  
• 備考：
  human astrocyte cell culture supernatant
• 参照：
  

• No.： 25
• 文献情報：
  Hyllner M et al. IL-6 and IL-8 response to erythropoietin therapy in radical hysterectomy. Acta Anaesthesiol Scand 2005 Jan;49(1):47-51
  Hyllner M et al
  2005/01/01
  
• 備考：
  Sample Type: Plasma (Citrate)
• 参照：
  

• No.： 26
• 文献情報：
  Sadeghi M et al. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection. Transpl. Int. 2005 Feb;18(2):177-85
  Sadeghi M et al
  2005/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified),Urine
• 参照：
  

• No.： 27
• 文献情報：
  Kaneyama K et al. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images. 2005 Apr;99(4):411-8
  Kaneyama K et al
  2005/01/01
  
• 備考：
  Sample Type: Synovial Fluid
• 参照：
  

• No.： 28
• 文献情報：
  Motivala SJ et al. Inflammatory markers and sleep disturbance in major depression. Psychosom Med ;67(2):187-94
  Motivala SJ et al
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 29
• 文献情報：
  Daniel V et al. Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients. Transplantation 2005 Jun;79(11):1498-506
  Daniel V et al
  2005/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 30
• 文献情報：
  Tsai MY et al. Effect of influenza vaccine on markers of inflammation and lipid profile. J. Lab. Clin. Med. 2005 Jun;145(6):323-7
  Tsai MY et al
  2005/01/01
  
• 備考：
  Sample Type: Plasma (EDTA)
• 参照：
  

• No.： 31
• 文献情報：
  Gotohda N et al. The role of a protease inhibitor against hepatectomy. Hepatogastroenterology ;53(67):115-9
  Gotohda N et al
  
• 備考：
  human plasma
• 参照：
  

• No.： 32
• 文献情報：
  Horiuchi S et al. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling. Int. J. Cancer 2006 Aug;119(4):823-30
  Horiuchi S et al
  2006/01/01
  
• 備考：
  Species: Human, Sample type: Cell Supernates
• 参照：
  

• No.： 33
• 文献情報：
  Adachi Y et al. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int. J. Cancer 2006 Sep;119(6):1303-11
  Adachi Y et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Cell Supernates
• 参照：
  

• No.： 34
• 文献情報：
  Richards PJ et al. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum. 2006 May;54(5):1662-72
  Richards PJ et al
  2006/01/01
  
• 備考：
  Species: Human, Sample type: Serum, Synovial Fluid
• 参照：
  

• No.： 35
• 文献情報：
  Collado-Hidalgo A et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin. Cancer Res. 2006 May;12(9):2759-66
  Collado-Hidalgo A et al
  2006/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 36
• 文献情報：
  Sadeghi M et al. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients. Transplantation 2006 Jun;81(12):1716-24
  Sadeghi M et al
  2006/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 37
• 文献情報：
  Mehra R et al. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch. Intern. Med. 2006 Sep;166(16):1725-31
  Mehra R et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Serum
• 参照：
  

• No.： 38
• 文献情報：
  Butler MO et al. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin. Cancer Res. 2007 Mar;13(6):1857-67
  Butler MO et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Cell Supernates
• 参照：
  

• No.： 39
• 文献情報：
  Cauley JA et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J. Bone Miner. Res. 2007 Jul;22(7):1088-95
  Cauley JA et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Serum
• 参照：
  

• No.： 40
• 文献情報：
  Chalaris A et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 2007 Sep;110(6):1748-55
  Chalaris A et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Cell Supernates
• 参照：
  

• No.： 41
• 文献情報：
  Sadeghi M et al. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 2007 Jul;23(7):886-90
  Sadeghi M et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Plasma (Not Specified)
• 参照：
  

• No.： 42
• 文献情報：
  Su S et al. Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis 2008 Sep;200(1):213-20
  Su S et al
  2008/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 43
• 文献情報：
  Shariat SF et al. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin. Cancer Res. 2008 Jun;14(12):3785-91
  Shariat SF et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Plasma (Citrate)
• 参照：
  

• No.： 44
• 文献情報：
  Nishimoto N et al. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
  Nishimoto N et al
  2008/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 45
• 文献情報：
  Egler RA et al. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma. Clin. Cancer Res. 2008 Nov;14(21):7028-34
  Egler RA et al
  2008/01/01
  
• 備考：
  Sample Type: Plasma (Heparin)
• 参照：
  

• No.： 46
• 文献情報：
  Perez-Andres M et al. Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease. Int. J. Cancer
  Perez-Andres M et al
  2009/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 47
• 文献情報：
  Ara T et al. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 2009 Jan;69(1):329-37
  Ara T et al
  2009/01/01
  
• 備考：
  Sample Type: Cell Supernates,Serum,bone marrow
• 参照：
  

• No.： 48
• 文献情報：
  Fuligni AJ et al. Daily family assistance and inflammation among adolescents from Latin American and European backgrounds. Brain Behav. Immun. 2009 Aug;23(6):803-9
  Fuligni AJ et al
  2009/01/01
  
• 備考：
  Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 49
• 文献情報：
  Chauhan D et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell 2009 Oct;16(4):309-23
  Chauhan D et al
  2009/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 50
• 文献情報：
  Sadeghi M et al. Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria. Transplantation 2009 Nov;88(9):1109-16
  Sadeghi M et al
  2009/01/01
  
• 備考：
  Sample Type: Urine
• 参照：
  

• No.： 51
• 文献情報：
  Holmlund U et al. Maternal country of origin, breast milk characteristics and potential influences on immunity in offspring. Clin. Exp. Immunol. 2010 Dec;162(3):500-9
  Holmlund U et al
  2010/01/01
  
• 備考：
  Sample Type: breast milk
• 参照：
  

• No.： 52
• 文献情報：
  Horiuchi S et al. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy. Immunology 1998 Nov;95(3):360-9
  Horiuchi S et al
  1998/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 53
• 文献情報：
  Lukashevich IS et al. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol. 2003 Feb;77(3):1727-37
  Lukashevich IS et al
  2003/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 54
• 文献情報：
  Barbour KE et al. Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J. Bone Miner. Res. 2012 May;27(5):1167-76
  Barbour KE et al
  2012/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 55
• 文献情報：
  Tai YT et al. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood 2012 Aug;120(9):1877-87
  Tai YT et al
  2012/01/01
  
• 備考：
  Sample Type: recombinant IL-6 R in mouse serum
• 参照：
  

• No.： 56
• 文献情報：
  Salsano E et al. An autoinflammatory neurological disease due to interleukin 6 hypersecretion. J Neuroinflammation 2013;10:29
  Salsano E et al
  2013/01/01
  
• 備考：
  Sample Type: CSF,Serum
• 参照：
  

• No.： 57
• 文献情報：
  Csaszar E et al. Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood 2014 Jan;123(5):650-8
  Csaszar E et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Culture Supernates
• 参照：
  

• No.： 58
• 文献情報：
  Kawada M et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE 2015;10(3):e0119415
  Kawada M et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Culture Supernates
• 参照：
  

• No.： 59
• 文献情報：
  Zhong H et al. A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Res. 2016 Jan;76(2):480-90
  Zhong H et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Culture Supernates
• 参照：
  

• No.： 60
• 文献情報：
  Cauley JA et al. Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the Osteoporotic Fractures in Men (MrOS). J. Bone Miner. Res. 2016 Dec;31(12):2129-2138
  Cauley JA et al
  2016/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 61
• 文献情報：
  Uchibori T et al. IL-6 trans-signaling is another pathway to upregulate Osteopontin. Cytokine 2017 Feb;90:88-95
  Uchibori T et al
  2017/01/01
  
• 備考：
  Sample Type: Cell culture supernatant
• 参照：
  

• No.： 62
• 文献情報：
  Cauley JA et al. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr 2016 Dec;16(1):213
  Cauley JA et al
  2016/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 63
• 文献情報：
  Munir H et al. Adipogenic Differentiation of Mesenchymal Stem Cells Alters Their Immunomodulatory Properties in a Tissue-Specific Manner. Stem Cells 2017 Jun;35(6):1636-1646
  Munir H et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Culture Supernates
• 参照：
  

• No.： 64
• 文献情報：
  Srikanth P et al. Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men. Osteoporos Int 2016 07;27(7):2291-2300
  Srikanth P et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 65
• 文献情報：
  Loh KP et al. Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. J Geriatr Oncol 2019 Apr;
  Loh KP et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 66
• 文献情報：
  Osuka K et al. Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas. J. Neurotrauma 2017 Jun;34(11):1996-2000
  Osuka K et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 67
• 文献情報：
  Ishikawa S et al. Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report. Transplant Proc 2018 Apr;50(3):869-872
  Ishikawa S et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 68
• 文献情報：
  Nordeng J et al. The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI. Mediators Inflamm 2021;2021:5525917
  Nordeng J et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：